Status:

COMPLETED

Bioavailability of the Fixed Combination of Amodiaquine and Artesunate Under Fed & Fasted Conditions

Lead Sponsor:

Sanofi

Conditions:

Malaria

Eligibility:

MALE

18-50 years

Phase:

PHASE1

Brief Summary

* Primary Objective: to evaluate the interaction with food after a single oral dose of a fixed combination of amodiaquine (AQ) and artesunate (AS) (COARSUCAM™) in healthy male subjects * Secondary Obj...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Healthy Caucasian subjects
  • Weight between 50 kg and 90 kg. 18 ≤ Body Mass Index ≤ 28 kg/m2.
  • The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Exclusion

    Key Trial Info

    Start Date :

    June 1 2006

    Trial Type :

    INTERVENTIONAL

    End Date :

    Estimated Enrollment :

    22 Patients enrolled

    Trial Details

    Trial ID

    NCT00386503

    Start Date

    June 1 2006

    Last Update

    December 9 2008

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Sanofi-Aventis

    Paris, France